POMPA MARK A

Through February 2024, the file is an executive's. EMCOR Group accounts for 957 of his 1,042 filings — a run that opens in January 2004 and cumulates to 653,363 shares sold against exactly 300 bought. That one-sidedness is the ordinary physiology of a CFO paid in equity over twenty years, and the chapter's closing rows are almost ceremonial: a 16-share grant on January 31, 2024, then a final code-F row on February 29, 2024 — 3,876 shares withheld for taxes at $313.52 — and silence from EMCOR ever since. No exit sale, no dramatic final disposition; the record just stops, the way an executive file does when the executive role ends.

From mid-2024 onward, the file is a director's. The Apogee Enterprises rows — 84 filings since October 2018, zero shares bought or sold — run on a clean quarterly clock: paired code-A grants at each quarter-end (147 and 60 shares on June 30, 2026; 199 and 80 on March 31, 2026; 145 and 59 at $43.57 on September 30, 2025) plus a larger annual award each June (1,893 shares in 2024, 2,954 in 2025, 2,741 in 2026). The share counts carry their own signal: the quarterly retainers grew from roughly 120 shares to nearly 280 combined while the grant-date prices in the payload slid from $59.20 in March 2024 to $70.02 that September, then down through $46.33, $40.60, and $43.57 across 2025. Fixed-dollar compensation resized by a falling stock — the growing 'insider acquisitions' at Apogee measure price weakness, not appetite.